{"disease":{"id":"pneumococcal-infectious-disease","name":"Pneumococcal infectious disease","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"fusidic-acid","indication_name":"Pneumococcal infectious disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"lincomycin","indication_name":"Pneumococcal infectious disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lincocin","generic_name":"LINCOMYCIN","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"lincomycin","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07071701","title":"A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population","phase":"","overall_status":"COMPLETED","enrollment_count":19267,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT06617715","title":"Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":3080,"lead_sponsor_name":"Sinovac Life Sciences Co., Ltd.","has_results":false},{"nct_id":"NCT06678607","title":"Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Shanghai Reinovax Biologics Co.,LTD","has_results":false},{"nct_id":"NCT06474377","title":"Clinical Trial of PCV24 in Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":170,"lead_sponsor_name":"Sinovac Life Sciences Co., Ltd.","has_results":false},{"nct_id":"NCT06183216","title":"A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Sinovac Research and Development Co., Ltd.","has_results":false},{"nct_id":"NCT06550830","title":"Clinical Trial of PCV24 in Children Aged 2-17 Years","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Sinovac Life Sciences Co., Ltd.","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}